USP22缺陷通过PU.1依赖机制促进致癌Kras激活后的髓系白血病发生
在表达致癌KrasG12D/+的小鼠中,USP22缺陷导致生存期缩短,髓系分化受阻并发生急性髓系白血病;该效应为细胞自主性,USP22缺陷的KrasG12D/+祖细胞转录组类似白血病干细胞,且USP22作为PU.1去泛素化酶正调控其蛋白稳定性,过表达PU.1可挽救分化。
要点
- USP22缺陷在KrasG12D/+小鼠中促进急性髓系白血病转化并缩短生存期。
- USP22缺陷的KrasG12D/+祖细胞转录组类似白血病干细胞,与AML不良预后基因高度相关。
- USP22通过正调控PU.1蛋白稳定性发挥作用,过表达PU.1可挽救分化。
核心结论
- USP22缺陷通过PU.1依赖机制促进Ras诱导的髓系白血病发生,揭示了USP22在癌变中的意外作用。
研究设计与样本
- 研究采用表达致癌KrasG12D/+的小鼠模型,并进行了骨髓移植实验。
主要发现
- USP22缺陷的KrasG12D/+小鼠较对照小鼠生存期缩短,原因是髓系细胞分化受阻导致急性髓系白血病。
- 移植USP22缺陷的KrasG12D/+细胞的小鼠发生侵袭性疾病并快速死亡,表明效应为细胞自主性。
- USP22缺陷的KrasG12D/+祖细胞转录组类似白血病干细胞,且与AML不良预后相关基因高度相关。
- USP22作为PU.1去泛素化酶正调控其蛋白稳定性并促进PU.1靶基因表达。
- 在USP22缺陷的KrasG12D/+祖细胞中过表达PU.1可挽救其分化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ras mutations are commonly observed in juvenile myelomonocytic leukemia (JMML) and chronic myelomonocytic leukemia (CMML). JMML and CMML transform into acute myeloid leukemia (AML) in about 10% and 50% of patients, respectively. However, how additional events cooperate with Ras to promote this transformation are largely unknown. We show that absence of the ubiquitin-specific peptidase 22 (USP22), a component of the Spt-Ada-GCN5-acetyltransferase chromatin-remodeling complex that is linked to cancer progression, unexpectedly promotes AML transformation in mice expressing oncogenic KrasG12D/+ USP22 deficiency in KrasG12D/+ mice resulted in shorter survival compared with control mice. This was due to a block in myeloid cell differentiation leading to the generation of AML. This effect was cell autonomous because mice transplanted with USP22-deficient KrasG12D/+ cells developed an aggressive disease and died rapidly. The transcriptome profile of USP22-deficient KrasG12D/+ progenitors resembled leukemic stem cells and was highly correlated with genes associated with poor prognosis in AML. We show that USP22 functions as a PU.1 deubiquitylase by positively regulating its protein stability and promoting the expression of PU.1 target genes. Reconstitution of PU.1 overexpression in USP22-deficient KrasG12D/+ progenitors rescued their differentiation. Our findings uncovered an unexpected role for USP22 in Ras-induced leukemogenesis and provide further insights into the function of USP22 in carcinogenesis.
引用
- Melo-Cardenas J, Xu Y, Wei J, et al. USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism. Blood. 2018. PMID: 29844011. doi:10.1182/blood-2017-10-811760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。